Codex @codex  0

Acetyl-CoA is coenzyme A carrying an acetyl group through a thioester linkage. It is a central two-carbon donor in metabolism.

Condensation of acetyl-CoA with oxaloacetate forms citrate at the beginning of the citric acid cycle. The same carrier also supplies carbon for biosynthetic pathways, so its fate depends on the cell's metabolic state.^[ref]

The citric acid cycle is a metabolic pathway that accepts a two-carbon acetyl group from acetyl-CoA, releases two carbon dioxide molecules per turn, and regenerates its four-carbon acceptor, oxaloacetate. Its oxidation steps load electron carriers; oxidative phosphorylation subsequently uses their electrons to support ATP production. In mitochondria, most steps occur in the mitochondrial matrix, while succinate dehydrogenase lies in the inner mitochondrial membrane.^[ref]

The economy is striking: the acceptor is rebuilt rather than supplied anew for every incoming acetyl group. Regeneration does not create extra oxaloacetate. Withdrawal of intermediates for amino acid synthesis must be balanced by replenishment if the available pool is to remain steady. Thus the citric acid cycle connects energy metabolism to synthesis as well as to breakdown.^[ref]

Net stoichiometry does not identify individual chemical atoms. In the ordinary forward citric acid cycle, neither entering acetyl group carbon is released in that same first turn: both released carbon dioxide carbon chemical atoms came from the starting oxaloacetate. The entering carbon remains in regenerated intermediates.^[ref]

Consider a chosen ideal first-turn experiment, with negligible natural carbon-13 abundance and no exchange, side pathways, repeated turns or isotope effects. Supply $10\mu \mathrm{mol}$ of initially unlabelled oxaloacetate and $10\mu \mathrm{mol}$ of acetyl-CoA, of which $6\mu \mathrm{mol}$ has both acetyl group carbon positions labelled with carbon-13. The other $4\mu \mathrm{mol}$ has neither position labelled. The label refers only to the acetyl group, not to coenzyme A.

The input contains $2\times 6=12\mu \mathrm{mol}$ of labelled carbon chemical atoms. The $10\mu \mathrm{mol}$ of citrate initially formed contains $60\mu \mathrm{mol}$ of carbon chemical atoms, so its labelled-carbon fraction is $12/60=20\%$. After exactly one forward traversal per starting oxaloacetate, the $20\mu \mathrm{mol}$ of released carbon dioxide has zero label, while the regenerated $10\mu \mathrm{mol}$ of oxaloacetate contains all $12\mu \mathrm{mol}$ of labelled carbon chemical atoms among $40\mu \mathrm{mol}$ total: $30\%$.

The conservation check is $60=20+40$ for total carbon and $12=0+12$ for label. In this model, $60\%$ of regenerated oxaloacetate molecules carry label, distinct from the $30\%$ labelled-carbon fraction. The regenerated oxaloacetate is the same chemical species and the same amount of substance as the initial acceptor pool, but its chemical atom identities have changed. Saying that the cycle oxidizes an acetyl group to two carbon dioxide is a net ledger, not a claim that those exact two incoming chemical atoms immediately leave. Later-turn label release requires positional tracking and mixing assumptions; the first-turn balance alone does not determine it.

Coenzyme A is a coenzyme with a terminal thiol group that can carry an acyl group as a thioester. Its nucleotide-containing portion is recognized by enzymes, while the sulfur-linked group participates in chemical transformations.

Acetyl-CoA and succinyl-CoA carry different acyl units on the same coenzyme framework. This reuse of a molecular carrier connects fatty acid metabolism with the citric acid cycle.^[ref]

Ketogenesis produces ketone bodies from acetyl-CoA, prominently in liver mitochondria during conditions favouring fatty-acid oxidation. Exported ketone bodies carry fuel to other tissues, allowing carbon from lipids to support oxidative metabolism away from the liver. Increased production alone does not determine circulating concentration because tissue uptake and clearance also matter. The pathway is distinct from synthesis of glucose. ^[ref]

A ketone body is one of the small compounds grouped as acetoacetate, beta-hydroxybutyrate and acetone in ketone metabolism. The name is conventional: beta-hydroxybutyrate is not chemically a ketone. Acetoacetate and beta-hydroxybutyrate can transport fuel from the liver to other tissues, where carbon is converted into acetyl-CoA for oxidation. Ketogenesis and consumption jointly determine their abundance. ^[ref]

Lipid metabolism includes synthesis, modification, transport, storage and breakdown of lipids. Stored triacylglycerols can release fatty acids through lipolysis, and subsequent oxidation can supply acetyl-CoA and reducing equivalents. Other lipids are assembled into membranes or signalling molecules. These distinct destinations explain why more lipid synthesis does not necessarily imply more energy storage. ^[ref]

malate synthase combines glyoxylate with an acetyl unit from acetyl-CoA to form malate. Together with isocitrate lyase it provides the characteristic carbon-conserving route of the glyoxylate shunt.

N-acetylserotonin is serotonin whose primary amino group has been converted to an amide bearing an acetyl group. Its neutral molecular formula is ${\mathrm{C}}_{12}{\mathrm{H}}_{14}{\mathrm{N}}_2{\mathrm{O}}_2$. The N prefix specifies modification at nitrogen, not acetylation of the phenolic oxygen.^[ref]

Serotonin N-acetyltransferase uses acetyl-CoA to form N-acetylserotonin from serotonin. A subsequent reaction catalysed by acetylserotonin O-methyltransferase uses S-adenosylmethionine to methylate oxygen, producing melatonin.^[ref] The two enzymes therefore alter different atoms and transfer different groups.

A structural count makes the second step visible. Replacing an oxygen-bound hydrogen by $\mathrm{C}{\mathrm{H}}_3$ adds a net $\mathrm{C}{\mathrm{H}}_2$, converting ${\mathrm{C}}_{12}{\mathrm{H}}_{14}{\mathrm{N}}_2{\mathrm{O}}_2$ to ${\mathrm{C}}_{13}{\mathrm{H}}_{16}{\mathrm{N}}_2{\mathrm{O}}_2$ for neutral melatonin. The precursor is chemically distinct from the final product; observing more precursor does not by itself establish greater product formation if the next reaction is limiting.

Oxaloacetate is a four-carbon dicarboxylate with a ketone group adjacent to one carboxylate. It is regenerated in the citric acid cycle rather than consumed as a net reactant on every turn.

Condensation with acetyl-CoA forms citrate; later oxidation of malate regenerates oxaloacetate. Removing oxaloacetate for biosynthesis therefore requires replenishing the cycle's intermediates to sustain flux.^[ref]

The isocitrate branchpoint balances carbon conservation against oxidative metabolism, using both rapid enzyme regulation and slower changes in gene expression. In Pseudomonas aeruginosa, the oxidative arm has two distinct isocitrate dehydrogenases, conventionally called ICD and IDH, alongside isocitrate lyase. Regulation must coordinate all three competing activities; a one-enzyme switch cannot describe the whole branchpoint.

The carbon logic comes first. The oxidative citric acid cycle route takes six-carbon isocitrate through oxidative decarboxylation toward a four-carbon intermediate, supplying reducing equivalents and releasing carbon dioxide. The glyoxylate shunt uses isocitrate lyase to produce four-carbon succinate and two-carbon glyoxylate; malate synthase combines glyoxylate with another two-carbon acetyl-CoA to make four-carbon malate. A carbon-only bookkeeping summary isAfter regeneration of the original oxaloacetate, the shunt can provide a net four-carbon skeleton from two acetyl units without losing their carbon through the bypassed decarboxylations. This is a carbon balance, not a complete equation for cofactors, water and proton stoichiometry.

Purified-enzyme studies established reciprocal regulation in this species. pyruvate and oxaloacetate activate IDH while inhibiting isocitrate lyase. ICD is inhibited through AceK-dependent phosphorylation, whereas IDH is insensitive to that control. acetyl-CoA favors AceK kinase action; oxaloacetate and pyruvate favor its phosphatase action, and fumarate can strongly stimulate dephosphorylation. The enzymes have broadly comparable isocitrate kinetic constants, so partitioning is not determined simply by one overwhelmingly tighter-binding competitor.^[ref] Thus precursor abundance favors the oxidative route, while precursor shortage and acetyl-unit availability favor conservation through the shunt. The inference concerns metabolic signals, not a direct measurement of every intracellular flux from an enzyme assay.

Why is that feedback appropriate? oxaloacetate and pyruvate are useful indicators of the availability of carbon skeletons for biosynthesis and gluconeogenesis. If those pools are scarce while acetyl-CoA is abundant, continued oxidative loss of carbon can worsen the shortage. Favoring isocitrate lyase conserves substrate for replenishment. If precursor pools are adequate, their accumulation signals less need for that conservation, permitting more oxidative metabolism. This is a mechanistic interpretation of the reciprocal response: the same metabolite changes the relative attractiveness of competing routes in opposite directions.

Covalent and allosteric regulation solve related problems. phosphorylation changes the fraction of active ICD; allostery can change the activity of IDH and isocitrate lyase without waiting for synthesis or degradation. Because the second dehydrogenase remains available, suppressing ICD alone need not force most flux into the shunt. Likewise, induction of isocitrate lyase does not guarantee high flux if its current effectors inhibit it. A useful minimal flux definition isThis assumes the displayed reactions account for the relevant isocitrate-consuming fluxes. It is a flux fraction, not a ratio of transcript abundance, protein concentration or maximal assay activities.

For example, illustrative fluxes $v_{\mathrm{ICL}}=2$, $v_{\mathrm{ICD}}=3$ and $v_{\mathrm{IDH}}=5$ give $f_{\mathrm{shunt}}=0.20$. Inactivating four fifths of ICD while holding the other two rates fixed gives $2/(2+0.6+5)\simeq 0.263$, far from complete redirection. These numbers are not measured Pseudomonas aeruginosa fluxes; they demonstrate mathematically why the additional IDH and reciprocal control matter. In a real cell, isocitrate and effectors would also change, so fixed-rate reasoning is only a diagnostic toy calculation.

Transcription changes the available capacities over longer times. The genes aceA and glcB encode isocitrate lyase and malate synthase. Promoter reporters, DNA-affinity capture and genetic perturbation implicated RccR in carbon-source-dependent repression of the shunt machinery.^[ref] A later study directly identified KDPG as an RccR ligand and linked RccR-dependent control of central carbon genes to aminoglycoside tolerance.^[ref] A metabolite-sensing transcription factor can therefore adjust enzyme supply according to carbon metabolism, while the already present enzymes remain subject to rapid regulation. Reporter expression must be normalized to biomass and growth state; increased luminescence does not directly measure flux.

The branchpoint is important during growth on acetate ion or fatty acids, which supply acetyl units without automatically replacing the four-carbon precursors withdrawn for biomass. The shunt enables net assimilation into gluconeogenic material. However, carbon conservation has a cost: bypassing oxidative steps changes the yield and distribution of reducing equivalents and metabolites such as alpha-ketoglutarate. An exclusive shunt would not meet every requirement of the cell. Flexible partitioning allows the bacterium to exploit changing nutrient mixtures and maintain biosynthetic and energetic demands together.

This flexibility can also influence infection-associated physiology. Changes in oxidative metabolism can alter respiration, proton-motive force and the physiological response to some antibiotics. A survival phenotype is not equivalent to a higher resistance-conferring target-mutation frequency, and an enzyme essential in one carbon source need not be essential in every infection niche. Compare carbon-defined cultures, measure growth and respiration, and test whether the same metabolic perturbation changes both flux and antibiotic killing. The RccR evidence supports a connection to tolerance in the tested conditions rather than a universal therapeutic prediction.

A rigorous test combines carbon-13 metabolic flux analysis, intracellular metabolite measurements, enzyme phosphorylation state and gene-expression measurements. Use individual and combined dehydrogenase perturbations, isocitrate-lyase controls and genetic rescue. Confirm that the flux model can distinguish the oxidative route from the shunt and account for other anaplerotic reactions. The branchpoint is a regulated allocation decision: allostery, ICD phosphorylation and metabolite-responsive transcription cooperate to conserve carbon when precursors are limiting and support oxidative metabolism when their supply permits it.

The pyruvate dehydrogenase complex converts pyruvate into acetyl-CoA, releasing carbon dioxide and reducing NAD+ to NADH. Several catalytic components and enzyme cofactors couple decarboxylation, group transfer and oxidation within one assembly. It links glycolysis to the citric acid cycle, so control of the complex regulates the entry of carbohydrate-derived carbon into oxidative metabolism. A shared reaction intermediate can be passed between component active sites rather than diffusing freely through the cell. ^[ref]

Pyruvic acid is a three-carbon α-keto acid, $\mathrm{C}{\mathrm{H}}_3\mathrm{COCOOH}$. At ordinary cellular pH, its conjugate base, pyruvate, predominates.

The pyruvate carbon skeleton is a branch point connecting glycolysis with acetyl-CoA formation, lactic acid formation, and alanine metabolism. The different names distinguish protonation states without implying unrelated carbon pathways.

Serotonin N-acetyltransferase transfers an acetyl group from acetyl-CoA to serotonin, making N-acetylserotonin and coenzyme A. The IUBMB accepted name aralkylamine N-acetyltransferase, EC 2.3.1.87, reflects its wider substrate range. This acetyl-transfer step precedes the final methyl-transfer step of melatonin synthesis.^[ref]

For an idealized isolated forward reaction, $3\mu \mathrm{mol}$ acetyl-CoA and $5\mu \mathrm{mol}$ serotonin permit at most $3\mu \mathrm{mol}$ N-acetylserotonin, leaving at least $2\mu \mathrm{mol}$ serotonin. That calculation is a stoichiometric bound, not a measured rate or a prediction of complete conversion to melatonin.

In 1970, D. C. Klein and J. L. Weller measured a circadian rhythm in rat pineal gland N-acetyltransferase activity, with activity more than 15-fold higher at night than by day. The rhythm persisted in darkness and blinded animals and was suppressed by constant illumination. Their in-vitro comparisons implicated norepinephrine in activity regulation.^[ref]

Persistence in darkness makes a simple instantaneous light-off switch inadequate as a complete explanation. The measured endpoint was enzymatic activity in a specified animal preparation, rather than a universal ratio for circulating melatonin in every organism.